Serial 98404839
Live / Allowed — Third extension granted (statement of use) (as of 10 Nov 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 14 Feb 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98404839
- Mark type
- Design / logo
- Filed
- 14 Feb 2024
- Published for opposition
- 11 Mar 2025
- Attorney of record
- Allison Strickland Ricketts
Goods and services
- Class 042 — Scientific and technological services: providing medical research information in the field of pharmaceuticals and clinical trials focusing on other endocrine diseases and disorders; Conducting clinical trials for pharmaceutical preparations for the treatment of congenital adrenal hyperplasia and other endocrine diseases and disorders; conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results
- Class 044 — Medical, beauty and agricultural services: providing medical information to patients, medical professionals in the field of other endocrine diseases and disorders; providing medical information to insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders; online information services, namely, providing medical information to patients, medical professionals in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders
Owner
- Neurocrine Biosciences, Inc., San Diego, CA, US
- Neurocrine Biosciences, Inc., San Diego, CA, US
Prosecution history
- 10 Nov 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Nov 2026 — CORRECTED NOA E-MAILED
- 10 Nov 2026 — SOU EXTENSION 3 GRANTED
- 05 Nov 2026 — SOU EXTENSION 3 FILED
- 10 Nov 2026 — DIVISIONAL PROCESSING COMPLETE
- 05 Nov 2026 — DIVISIONAL REQUEST RECEIVED
- 05 Nov 2026 — TEAS REQUEST TO DIVIDE RECEIVED
- 05 Nov 2026 — SOU TEAS EXTENSION RECEIVED
- 30 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Apr 2026 — SOU EXTENSION 2 GRANTED
- 28 Apr 2026 — SOU EXTENSION 2 FILED
- 28 Apr 2026 — SOU TEAS EXTENSION RECEIVED
- 14 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Nov 2025 — SOU EXTENSION 1 GRANTED
- 06 Nov 2025 — SOU EXTENSION 1 FILED